Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

February 28, 2013

Conditions

Fasting

Interventions

DRUG

Metformin Hydrochloride Extended-Release Tablets USP 750 mg

Metformin Hydrochloride Extended-Release Tablets 750 mg once a day

DRUG

GLUCOPHAGE®XR

GLUCOPHAGE®XR 750 mg once a day

Trial Locations (1)

Veeda Clinical Research Pvt. Ltd., Ahmedabad